153 related articles for article (PubMed ID: 25886078)
1. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.
Saher O; Ghorab DM; Mursi NM
Pharm Dev Technol; 2016 Aug; 21(5):600-10. PubMed ID: 25886078
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
Bhalerao H; Koteshwara KB; Chandran S
AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
[TBL] [Abstract][Full Text] [Related]
3. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.
Sultana Y; Aqil M; Ali A
Drug Deliv; 2006; 13(3):215-9. PubMed ID: 16556574
[TBL] [Abstract][Full Text] [Related]
4. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A
J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
[TBL] [Abstract][Full Text] [Related]
5. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A; Anwer A
Drug Dev Ind Pharm; 2003 Feb; 29(2):215-21. PubMed ID: 12648018
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
8. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
Balasubramaniam J; Pandit JK
Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
[TBL] [Abstract][Full Text] [Related]
9. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
[TBL] [Abstract][Full Text] [Related]
10. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
Maulvi FA; Singhania SS; Desai AR; Shukla MR; Tannk AS; Ranch KM; Vyas BA; Shah DO
Int J Pharm; 2018 Sep; 548(1):139-150. PubMed ID: 29960036
[TBL] [Abstract][Full Text] [Related]
11. In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management.
Okur NÜ; Yozgatli V; Okur ME
Drug Dev Res; 2020 Sep; 81(6):716-727. PubMed ID: 32359095
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment.
Imam SS; Bukhari SNA; Ali A
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):959-967. PubMed ID: 28708424
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic delivery of sparfloxacin from in situ gel formulation for treatment of experimentally induced bacterial keratitis.
Nesseem DI
Drug Test Anal; 2011 Feb; 3(2):106-15. PubMed ID: 21322120
[TBL] [Abstract][Full Text] [Related]
14. Study of hydroxy propyl guar derivative for its gelling property and it's use in the formulation of tenoxicam gels.
Swamy NG; Dharmarajan TS; Paranjothi KL
Pak J Pharm Sci; 2007 Jan; 20(1):61-6. PubMed ID: 17337431
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: hydroxypropyl-beta-cyclodextrin complex.
Başaran B; Bozkir A
Acta Pol Pharm; 2012; 69(6):1137-47. PubMed ID: 23285675
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
[TBL] [Abstract][Full Text] [Related]
17. Preparation of a novel tacrolimus ion sensitive ocular in situ gel and
Sun J; Sun X
Pharm Dev Technol; 2022 Apr; 27(4):399-405. PubMed ID: 35579910
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
Patel UL; Chotai NP; Nagda CD
Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
[TBL] [Abstract][Full Text] [Related]
20. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
Ma WD; Xu H; Wang C; Nie SF; Pan WS
Int J Pharm; 2008 Feb; 350(1-2):247-56. PubMed ID: 17961940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
